Equities

US Physical Therapy Inc

US Physical Therapy Inc

Actions
  • Price (EUR)89.50
  • Today's Change1.50 / 1.70%
  • Shares traded0.00
  • 1 Year change+12.58%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year US Physical Therapy Inc had net income fall -12.19% from 32.16m to 28.24m despite a 9.34% increase in revenues from 553.14m to 604.80m.
Gross margin19.41%
Net profit margin4.93%
Operating margin7.40%
Return on assets3.12%
Return on equity2.89%
Return on investment4.31%
More ▼

Cash flow in USDView more

In 2023, US Physical Therapy Inc increased its cash reserves by 383.72%, or 121.23m. Cash Flow from Financing totalled 84.27m or 13.93% of revenues. In addition the company generated 81.98m in cash from operations while cash used for investing totalled 45.02m.
Cash flow per share3.25
Price/Cash flow per share29.30
Book value per share32.21
Tangible book value per share-13.09
More ▼

Balance sheet in USDView more

US Physical Therapy Inc has a Debt to Total Capital ratio of 17.53%, a lower figure than the previous year's 28.76%.
Current ratio1.78
Quick ratio--
Total debt/total equity0.2952
Total debt/total capital0.1753
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)--
Div growth rate (5 year)13.33%
Payout ratio (TTM)139.78%
EPS growth(5 years)-0.4999
EPS (TTM) vs
TTM 1 year ago
-45.34
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.